Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study

There is currently an outbreak of respiratory disease caused by a novel coronavirus. The virus has been named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease it causes has been named coronavirus disease 2019 (COVID-19). More than 16% of patients developed acute respiratory distress syndrome, and the fatality ratio was 1%–2%. No specific treatment has been reported. Her

[hihi01]

そりゃ、もう日本がまだコロナから回復しては困るという政治的理由でしょう。

[yoyoprofane]

“This article has been withdrawn at the request of the author(s) and/or editor.”